In this issue:
Dolutegravir as HIV post-exposure prophylaxis
HIV-1 drug resistance mutations in ART-naive patients
Switching from TDF to TAF
Second TAF switching study
Socioeconomic factors in suboptimal ART adherence
Antiretrovirals, fractures and osteonecrosis
HIV viral escape in the central nervous system
Blood-brain barrier disruption during primary HIV infection
Herpes simplex virus type 2 after TD
Hepatitis A vaccination: 2 or 3 doses
Please login below to download this issue (PDF)